Mammography

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Breast Arterial Calcifications as an Imaging Biomarker of Cardiovascular Risk

Prospective Case Collection Study for New Mammography Technologies

Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy

Artificial Intelligence in Mammography-Based Breast Cancer Screening

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

Weight Loss and Breast Cancer

Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer

Improving Access to Breast Cancer Screening and Treatment in Nigeria: The Triple Mobile Assessment and Patient Navigation Model

Imagio Feasibility Multi-Reader, Multi-Case Study

Development of Artificial Intelligence System for Detection and Diagnosis of Breast Lesion Using Mammography

Optoacoustic Images Versus Imagio® Ultrasound

Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery